Clinical Trials Browser

Phase 1/2 × Suspended × Carcinoma, Hepatocellular × Clear all

NCT05603572 2025-06-05

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Phase 1/2 Suspended

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular

NCT02026362 2017-10-18

HCC DC CTL

Phase 1/2 Suspended

Gastrointestinal

Carcinoma, Hepatocellular